Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Scientific Reports|April 27, 2019
Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survivalMayuko Uehara, Xiaofei Li, Amir Sheikhi, et al.Frontiers in Immunology|February 3, 2022
Characterization of Leptin Receptor+ Stromal Cells in Lymph NodeLiwei Jiang, Mine Yilmaz, Mayuko Uehara, et al.Scientific Reports|February 8, 2018
Ischemia augments alloimmune injury through IL-6-driven CD4+ alloreactivityMayuko Uehara, Zhabiz Solhjou, Naima Banouni, et al.JCI Insight|July 13, 2018
Repetitive ischemic injuries to the kidneys result in lymph node fibrosis and impaired healingOmar H Maarouf, Mayuko Uehara, Vivek Kasinath, et al.The Journal of Clinical Investigation|May 1, 2025
CXCL12+ fibroblastic reticular cells in lymph nodes facilitate immune tolerance by regulating T cell-mediated alloimmunityYuta Yamamura, Gianmarco Sabiu, Jing Zhao, et al.Circulation|February 20, 2026
HEV-Targeted Antibody-Drug Conjugate Promotes Long-Term Cardiac Allograft AcceptanceYanjia Che, Yuta Yamamura, Sungwook Jung, et al.Frontiers in Immunology|August 29, 2022
Characterization of CD41+ cells in the lymph nodeLi Dai, Mayuko Uehara, Xiaofei Li, et al.The Journal of Clinical Investigation|October 3, 2018
Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survivalBaharak Bahmani, Mayuko Uehara, Liwei Jiang, et al.The Journal of Clinical Investigation|December 15, 2022
Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in miceJing Zhao, Sungwook Jung, Xiaofei Li, et al.Advanced Materials (Deerfield Beach, Fla.)|June 26, 2023
Nanotargeted Delivery of Immune Therapeutics in Type 1 DiabetesSungwook Jung, Moufida Ben Nasr, Baharak Bahmani, et al.Pageof 4